Catheter-Based Transcoronary Myocardial Hypothermia Attenuates Arrhythmia and Myocardial Necrosis in Pigs With Acute Myocardial Infarction
Hiromasa Otake, MD,
Junya Shite, MD*,
Oscar Luis Paredes, MD,
Toshiro Shinke, MD,
Ryohei Yoshikawa, MD,
Yusuke Tanino, MD,
Satoshi Watanabe, MD,
Toru Ozawa, MD,
Daisuke Matsumoto, MD,
Daisuke Ogasawara, MD and
Mitsuhiro Yokoyama, MD
Division of Cardiovascular and Respiratory Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe, Japan.
Manuscript received February 16, 2006;
revised manuscript received June 9, 2006,
accepted June 19, 2006.
* Reprint requests and correspondence: Dr. Junya Shite, Kobe University Graduate School of Medicine, Department of Cardiology, 7-5-1 Kusunoki-cho, Chuo-ku, Kobe, Hyogo, 650-0017, Japan. (Email: shite{at}med.kobe-u.ac.jp).
 |
Abstract
|
|---|
OBJECTIVES: This study evaluated the efficacy of catheter-based transcoronary myocardial hypothermia (CTMH) in pigs with acute myocardial ischemia.
BACKGROUND: Although it has been suggested that hypothermia therapy can attenuate myocardial necrosis, few applications have been accepted for clinical use.
METHODS: This study comprises 2 substudies. In both studies, pigs underwent 60 min of coronary occlusion and 180 min of reperfusion. In study 1, after 15 min of coronary occlusion with an over-the-wire-type balloon (OTWB), pigs in the hypothermia group (H) (n = 13) were directly infused with 4°C saline into the coronary artery through the OTWB wire lumen (2.5 ml/min) for 60 min. Pigs in the normothermia group (N) (n = 15) received the same amount of 36.5°C saline. In study 2, pigs in the hypothermia-reperfusion group (HR) (n = 5) were infused with 4°C saline through the infusion catheter (8 ml/min) for 30 min with a later start (60 min after coronary occlusion), whereas simple reperfusion was used for the reperfusion group (R) (n = 6).
RESULTS: Catheter-based transcoronary myocardial hypothermia was successful in both studies. In study 1, CTMH significantly decreased ventricular arrhythmia and the ratio of necrosis to ischemic risk area (H: 9 ± 2%; N: 36 ± 4%; p < 0.0001) with a significant reduction of enzyme leaks. In study 2, CTMH tended to reduce the ratio of necrosis (HR: 33 ± 2%; R: 45 ± 5%; p = 0.08). In both studies, CTMH significantly suppressed the increase of 8-iso-prostaglandin F2 while preserving the coronary flow reserve.
CONCLUSIONS: Catheter-based transcoronary myocardial hypothermia reduced myocardial necrosis while preserving coronary flow reserve, due, in part, to attenuation of oxidative stress.
|
Abbreviations and Acronyms
| | APV = time-averaged peak velocity | | CFR = coronary flow reserve | | CKMB = creatinine kinase MB isozyme | | cTnT = cardiac troponin T | | LAD = left anterior descending coronary artery | | LV = left ventricle/ventricular | | LVdP/dtmax
= peak positive first derivative of left ventricle | | MI = myocardial infarction | | OTWB = over-the-wire-type balloon | | sVT = sustained ventricular tachycardia | | tau = time constant of left ventricular relaxation | | 8-iso-PGF2
= 8-iso-prostaglandin F2 |
|
Coronary reperfusion therapy is widely performed in patients with acute myocardial infarction (MI), although its cardioprotective effect remains unsatisfactory. Reperfusion injury induces persistent myocardial necrosis in conjunction with increased oxidative stress (1–3) and activity of cyto-kines (4,5), which are believed to be major factors contributing to the deterioration of cardiac function after coronary reperfusion therapy. Although several agents, such as antioxidants (6), genes (7), and hormones (8), have been administered as adjuncts to coronary reperfusion, their efficacy for preventing ischemic damage has been found lacking. Findings from preliminary animal studies, however, have shown that mild hypothermia markedly ameliorates tissue damage after the onset of ischemia in many organs (9–12). As for the heart, several experimental studies have demonstrated that mild hypothermia can minimize myocardial necrosis resulting from acute MI (13–16). Ongoing research into systemic core cooling with an endovascular cooling system for patients with acute MI has shown its safety (17). With this method, however, sufficient cooling of the ischemic myocardium cannot be attained due to severe shivering caused by lowering the whole body temperature, so that the apparent myocardial protective effect is negated.
Therefore, we developed a new method involving cold saline infusion into an infarct-related coronary artery by means of a catheter. With this method, the cooling effect was restricted to the ischemic myocardium, thus resulting in a substantial reduction in systemic complications. Furthermore, this technique is simple, so that it may be suitable for widespread clinical application. The purpose of the study presented here was to determine whether this method could effectively induce regional hypothermia as well as attenuate arrhythmia and myocardial injury in pigs with acute MI.
|
Methods
|
|---|
This study comprises 2 substudies. In study 1, we evaluated whether direct infusion of cold saline into the coronary artery could induce regional hypothermia and attenuate myocardial injury in pigs with ongoing ischemia. In study 2, to examine the clinical feasibility and efficacy of this procedure for acute MI, hypothermal-reperfusion therapy was initiated after a longer period of coronary occlusion and the result was compared with that obtained with simple immediate reperfusion-therapy in pigs with established MI.
Subjects.
Thirty-nine Yorkshire pigs (28 for study 1, 11 for study 2) were used, and the study procedure conformed to the Principles of Laboratory Animal Care formulated by the National Society for Medical Research and the Guide for the Care and Use of Laboratory Animals published by the U.S. National Institutes of Health.
Surgical preparation.
The pigs were sedated with intramuscular ketamine hydrochloride (20 mg/kg) and atropine sulfate (0.05 mg/kg). After tracheal intubation, deep anesthesia was induced with mechanical ventilation of oxygen and sevoflurane. Through a median sternotomy and systemic heparinization (100 U/kg intravenously/h), the pericardium was incised, and a deep body thermister (Coretemp CM-210, Terumo Co., Tokyo, Japan) to monitor the myocardial temperature at 5- to 6-mm depth was placed directly onto the area at risk of ischemia. A 6-F Swan-Ganz catheter (CCOM catheter; Terumo Co.) was advanced via the left internal jugular vein into the pulmonary artery to monitor cardiac output. A 5-F catheter was then inserted through the right internal jugular vein into the coronary sinus for blood sampling, while a 2-F micromanometer-tipped catheter (Millar Instruments, Houston, Texas) was advanced into the left ventricular (LV) cavity through a 5-F pigtail catheter via the right femoral artery for measuring peak positive first derivative of LV (LVdP/dtmax) and time constant of LV relaxation (tau). Finally, a 7-F angioplasty-guiding catheter (Heartrail, Terumo Co.) was used for entry into the left coronary from the right carotid artery.
Experimental procedure.
Figure 1
provides an overview of the study protocols. First, baseline hemodynamics, myocardial and rectal temperature, and blood samples were obtained. After coronary angiography, an over-the-wire type percutaneous transluminal coronary angioplasty balloon (OTWB) mounted on a 0.014-inch wire was advanced into the left anterior descending coronary artery (LAD), positioned at approximately one-third of the distance from the apex and inflated to occlude the LAD for 60 min. After 15 min of coronary occlusion, the pigs in study 1 were randomly assigned to the hypothermia or the normothermia group. For animals in the hypothermia group, cooled saline (4°C) was infused into the ischemic myocardium through the wire lumen of the OTWB at 2.5 ml/min (the maximum flow rate possible for this wire lumen). Pigs in the normothermia group were administered the same amount saline, but at 36.5°C in the same manner. After 60 min of coronary occlusion, reperfusion was achieved by complete deflation of the OTWB, and intracoronary saline infusion was continued for 15 min after reperfusion in both groups.
View larger version (48K):
[in this window]
[in a new window]
[Download PPT slide]
|
Figure 1 Study Protocol Over Time
(A) Coronary artery was occluded for 60 min. In study 1, intracoronary saline infusion (4°C or 36.5°C, 2.5 ml/min) with balloon inflation was started 15 min after coronary occlusion, and continued for 15 min after balloon deflation. In study 2, hypothermia with reperfusion (4°C, 8 ml/min) was initiated after 60 min occlusion and compared with simple reperfusion. (B) Angiographic frame showing the location of catheters, thermister (black arrow), and over-the-wire type percutaneous transluminal coronary angioplasty balloon (white arrow). (C) Schematic representation of regional myocardial hypothermia in the study.
|
|
In study 2, the LAD was occluded at the same position by using an infusion balloon (Helios, Avantec, Vascular Corporation, Sunnyvale, California), which has a larger lumen than conventional OTWB so that a higher volume of saline could be infused. After 60 min of coronary occlusion, pigs were assigned to the hypothermia-reperfusion group or the reperfusion group. For pigs in the hypothermia-reperfusion group, cooled saline (4°C) was infused through the infusion balloon at 8 ml/min for 30 min followed by complete balloon deflation. For pigs in the reperfusion group, simple reperfusion was used after 60 min of coronary occlusion. In both studies, reperfusion was observed for 180 min.
Incidence of arrhythmia.
Twenty-four-hour Holter recordings (Holtrec, Terumo Co.) were obtained and reviewed with the Holtrec Analysis System software to determine the total number of ventricular premature beats and sustained ventricular tachycardia (sVT). Ventricular premature beats were defined as the presence of at least 2 of 3 criteria: 1) atypical QRS configuration with alteration or inversion of the T wave; 2) post-extrasystolic pause; and 3) atrioventricular dissociation. Sustained ventricular tachycardia was defined as a fast ventricular rhythm of 15 or more beats in accordance with the Lambeth Conventions (18).
Coronary flow velocity measurements.
Intracoronary Doppler flow measurements were performed with a 0.014-inch Doppler-tipped guidewire (FloWire; Volcano Therapeutics, Inc., Rancho Cordova, California) and a velocimeter (FloMap; Volcano Therapeutics Inc.) at baseline, 60 min, and 180 min after reperfusion. Doppler flow velocity spectra were analyzed on-line to determine time-averaged peak velocity (APV) during 2 cardiac cycles. After measurement of the baseline APV, the hyperemic APV for intracoronary papaverine (10 mg) injection was recorded, and the coronary flow reserve (CFR) was obtained as the ratio of hyperemic APV to baseline APV.
Blood sample analysis.
Blood samples were obtained from coronary sinus at baseline and 180 min after reperfusion and stored at –80°C until analysis. To assess myocardial damage, creatinine kinase MB isozyme (CKMB) was measured with the aid of an Automated Chemiluminescence System (ADVIA Centaur; Bayer HealthCare, Leverkusen, Germany) with a detection limit of 5 ng/ml and the levels of cardiac troponin T (cTnT) were determined by means of a third-generation assay on an Elecsys 2010 (Roche Diagnostics, Indianapolis, Indiana), with a detection limit of 0.10 ng/ml. Production of 8-iso-prostaglandin F2 (8-iso-PGF2) was quantified for assessment of the oxidative stress by using an 8-Isoprostane EIA KIT (Cayman Chemical Company, Ann Arbor, Michigan).
Measurement of myocardial area at risk and necrosis.
At the end of the experiment, LAD was reoccluded, and 2% Evans blue was injected into the LV. After euthanasia, the heart was rapidly excised, and cut transversely into 0.5-cm thick slices, which were then photographed to identify the ischemic risk regions (not stained blue) and incubated in 2% triphenyl tetrazolium chloride for 20 min to delineate the area of necrosis. The ischemic and necrotic areas were traced and planimetered on each slice, and the results were summed to calculate the ratio of total necrotic area to ischemic area.
Histopathological assessment.
Left ventricular sections from the ischemic area from both groups were collected at the end of study 2 and fixed with 10% formalin for  48 h, frozen in OCT compound, sliced into 5-µm sections, and stained with hematoxylin-eosin for light microscopic examinations.
Determination of myocardial water content.
One aim of study 2 was to evaluate whether intracoronary saline infusion may cause myocardial edema. Post-experimental myocardium samples of 0.3 g were obtained from both the subendocardial and epicardial side of the ischemic area. The tissue was weighed and desiccated for 48 h at 80°C, and the percentage of water content was calculated as (wet weight – dry weight)/(wet weight) x 100.
Statistical analysis.
Statistical analysis was conducted with a commercially available software package (StatView 5.0, SAS Institute Inc., Cary, North Carolina). The differences between variables of the 2 groups were compared by using Student unpaired t test. Comparison of the ratio of pigs with sVT was performed with Fisher exact test. Two-way repeated measures analysis of variance followed by Bonferroni’s multiple-comparison t test was used to compare serial measurements of hemodynamic and coronary flow parameters. Results were expressed as the mean ± SEM, and a p value <0.05 was considered significant.
|
Results
|
|---|
Study 1.
Ameliorative effects of hypothermia on ongoing myocardial ischemia
One animal in the hypothermia and 3 in the normothermia group died of ventricular fibrillation, and their data were excluded from analysis. The body weight and LV weight of the remaining animals (hypothermia: 12; normothermia: 12) showed no significant differences between the 2 groups.
Changes in myocardial temperature associated with regional hypothermia
Figure 2A shows the changes in ischemic myocardial temperature. The baseline myocardial temperature of the 2 groups did not differ, but myocardial and rectal temperature of the normothermia group did not change throughout the study, whereas myocardial temperature of the hypothermia group started to decrease immediately after the start of cold saline infusion and reached a minimum (33.1 ± 0.5°C; 3.2°C absolute reduction) just before reperfusion. The temperature then increased gradually after reperfusion. In contrast with the dramatic change in myocardial temperature, rectal temperature remained constant for the hypothermia group (data not shown).
View larger version (18K):
[in this window]
[in a new window]
[Download PPT slide]
|
Figure 2 Changes in Ischemic Myocardial Temperature
Changes in ischemic myocardial temperature relative to baseline in study 1 (A) and in study 2 (B). Data are expressed as mean ± SEM.
|
|
Incidence of arrhythmia
The total number of ventricular premature beats was significantly less for the hypothermia group than for the normothermia group (246 ± 66 vs. 476 ± 30, p = 0.019), as was the ratio of pigs with at least 1 episode of sVT during the study (33% vs. 73%, p = 0.024 by Fisher exact test).
Hemodynamics and LV function
Figure 3
shows the changes in hemodynamic parameters. Mean arterial pressure, heart rate, and cardiac output were similar for the 2 groups. Systolic function assessed by LVdP/dtmax for the hypothermia group was markedly preserved at 60 min after reperfusion (103 ± 10.4% vs. 73.8 ± 6.7%, p < 0.001 by Bonferroni’s multiple-comparison t test). Diastolic performance assessed by tau did not show any statistical difference between the 2 groups.
View larger version (17K):
[in this window]
[in a new window]
[Download PPT slide]
|
Figure 3 Time Course of Hemodynamic Parameters in Study 1
The p value by 2-way analysis of variance: group difference <0.001 for peak positive first derivative of left ventricular pressure (LVdP/dtmax). *p < 0.001 versus normothermia group at the same stage by Bonferroni’s multiple-comparison t test. Data are expressed as mean ± SEM. CO = cardiac output; HR = heart rate; MAP = mean arterial pressure; Tau = time constant of left ventricular relaxation.
|
|
Doppler flow wire assessment of coronary blood flow
Baseline CFR of the 2 groups showed no difference; however, whereas the hypothermia group maintained its baseline level throughout the study, that of the normothermia group had decreased significantly 60 min and 180 min after reperfusion (60 min: 2.44 ± 0.19 vs. 1.81 ± 0.09, p < 0.001; 180 min: 2.58 ± 0.22 vs. 1.99 ± 0.14, p < 0.001 by Bonferroni’s multiple-comparison t test) (Fig. 4A).
View larger version (9K):
[in this window]
[in a new window]
[Download PPT slide]
|
Figure 4 Serial Changes in CFR by Study
Serial changes in coronary flow reserve (CFR) in study 1 (A) and in study 2 (B). The p value by 2-way analysis of variance: group <0.001, time course <0.001, group-time course interaction <0.001 for CFR from each study. Data are expressed as mean ± SEM. *p < 0.001 versus normothermia or reperfusion group at the same stage.  p < 0.001 versus baseline within the same group by Bonferroni’s multiple-comparison t test. bpm = beats/min.
|
|
Blood sample analysis for myocardial necrosis and oxidative stress
Baseline concentrations of CKMB, cTnT, and 8-iso-PGF2 in coronary sinus blood showed no significant differences between the 2 groups. However, the increases in these indexes 180 min after reperfusion were significantly less for the hypothermia group ( CKMB: 19.7 ± 3.7 ng/ml vs. 38.5 ± 7.7 ng/ml, p = 0.048; cTnT: 0.84 ± 0.19 ng/ml vs. 2.83 ± 0.83 ng/ml, p = 0.037; 8-iso-PGF2: –2.09 ± 1.98 pg/ml vs. 5.29 ± 1.97 pg/ml, p < 0.001) (Fig. 5A).
LV necrotic area in relation to ischemic risk area
Figure 6A shows that, although the ischemic risk area was the same for both groups (12 ± 2% vs. 13 ± 1%, p = 0.65), the ratio of total necrotic area to risk area for the hypothermia group was significantly lower than that for the normothermia group (9 ± 2% vs. 36 ± 4%, p < 0.0001). Figure 7
is a scattergram of the relationship between the necrotic area and the risk area, which clearly demonstrates that regional hypothermia dramatically reduced the necrotic area regardless of the ischemic risk area. Figure 8
shows representative photographs of LV sections from both groups.
View larger version (80K):
[in this window]
[in a new window]
[Download PPT slide]
|
Figure 8 Ischemic and Necrotic Myocardium of Representative Cases
Top panels show the ischemic risk myocardium (not stained blue), and bottom panels show the necrotic myocardium (white region). The heart treated with normothermia showed a larger area of necrosis than that with hypothermia.
|
|
Study 2.
Hypothermia for extended MI
In study 2, one animal in the reperfusion group died of ventricular fibrillation, and its data were excluded from analysis. Five animals each of the hypothermia-reperfusion and reperfusion groups were thus evaluated.
Figure 2B shows the changes in myocardial temperature. In the reperfusion group, myocardial temperature did not change during the study, whereas in the hypothermia-reperfusion group, the ischemic myocardial temperature began to decrease after the start of cooling and reached a level similar to that of the hypothermia group in study 1 (33.1 ± 0.4°C; 3.4°C absolute reduction) even after complete deflation of the balloon. As for CFR levels, the hypothermia-reperfusion group showed a higher CFR than that for the reperfusion group 60 min after reperfusion (2.14 ± 0.12 vs. 1.49 ± 0.26; p = 0.0001 by Bonferroni’s multiple-comparison t test) (Fig 4B). Blood sample analysis demonstrated that 8-iso-PGF2 for the hypothermia-reperfusion group was significantly smaller than that for the reperfusion group (–1.20 ± 1.24 pg/ml vs. 3.50 ± 0.87 pg/ml; p = 0.023), whereas CKMB and cTnT showed no significant differences between the 2 groups (CKMB: 40.7 ± 9.9 ng/ml vs. 46.7 ± 11.1 ng/ml, p = 0.71; cTnT: 1.78 ± 0.64 ng/ml vs. 2.26 ± 0.27 ng/ml, p = 0.56) (Fig. 5B).
Although the ischemic risk area was the same for both groups (12 ± 1% vs. 13 ± 3%; p = 0.72), the necrotic area for the hypothermia-reperfusion group tended to be smaller than that for the reperfusion group but without statistical significance (33 ± 2% vs. 45 ± 5%, p = 0.080) (Fig. 6B). Myocardial water content showed no difference between the 2 groups, indicating that saline infusion did not cause myocardial edema (Fig. 9). Histologic examination with hematoxylin-eosin staining disclosed no significant differences in gross hemorrhage, microscopic hemorrhagic infarction, or inflammatory cell infiltration between the 2 groups.
View larger version (22K):
[in this window]
[in a new window]
[Download PPT slide]
|
Figure 9 Myocardial Water Content in Study 2
Myocardial water content of myocardium from subendocardial and epicardial sides in reperfusion and hypothermia-reperfusion groups. Data are expressed as mean ± SEM.
|
|
|
Discussion
|
|---|
In this study, we achieved regional myocardial hypothermia by means of cold saline infusion via an OTWB catheter without accompanying hemodynamic deterioration or other adverse effects. Furthermore, hypothermia preserved CFR and dramatically reduced ongoing myocardial ischemia-related injury together with a reduction in ventricular arrhythmias and the extent of myocardial necrosis and attenuation of oxidative stress. Moreover, use of the infusion catheter, which makes it possible to infuse a larger amount of cold saline, enabled us to attain regional hypothermia without coronary artery occlusion. Indeed, once MI was established, hypothermia could not provide the same beneficial effects for ischemic necrosis as in the ongoing ischemia model. However, considering that this method suppressed the increase in 8-iso-PGF2 and maintained the CFR level, regional hypothermia may have some cardioprotective effect even in the case of established MI.
Previous studies of hypothermia for the prevention of ischemic injury.
Hypothermia is currently an established method used not only for surgical procedures such as cardiopulmonary bypass surgery and organ transplantation, but also in several high-risk clinical settings, including acute ischemic stroke, traumatic brain injury, and cardiac arrest (19–21). Although hypothermia has gained much attention primarily for its neuroprotective effects (19–21), recent research has provided evidence of its efficacy for myocardial protection as well (13–16). Dave et al. (16) succeeded in reducing the extent of myocardial infarcts by 49% with cold saline perfusion of the pericardiac cavity. They also demonstrated that hypothermia by direct application of an ice-filled bag to the risk zone initiated after 10 min of occlusion reduced infarct size by 50% (14). Although these studies clearly demonstrate the effectiveness of hypothermia for MI, the methods used to achieve hypothermia are too invasive to be implemented in clinical settings. Whereas systemic hypothermia attained with an endovascular cooling device for human acute MI has been shown to be safe, cooling of the ischemic myocardium is too slow, so that this method has not yet proven itself to be effective (17). Additionally, many patients undergoing systemic hypothermia suffered from episodic shivering due to reduced core body temperature.
Advantages of catheter-based transcoronary myocardial hypothermia.
This study demonstrated that cold saline infusion into the MI-related coronary artery successfully lowered myocardial temperature. One advantage of our method is that the localized effect within the ischemic myocardium is enhanced while systemic effects are reduced. Moreover, this method entailed few complications such as hemodynamic instability, coronary vasoconstriction, and bradycardia. On the contrary, we found that hypothermia-treated pigs were electrically more stable than control pigs. Although the mechanisms of the antiarrhythmic effect of hypothermia remain uncertain, regional hypothermia may help suppress myocardial electrical irritability during ischemia and reperfusion.
In study 1, regional myocardial hypothermia effectively reduced the elevation of CKMB and cTnT levels after reperfusion. Histochemical studies showed that hypothermia led to a 75% reduction in infarct size compared with that for the normothermia group. In spite of a modest decline in myocardial temperature, this cardioprotective effect was relatively pronounced compared with previous reports for cooling from the epicardium. We suggest that the success of our method may be primarily attributable to the route used for cooling, because transcoronary hypothermia may lower myocardial temperature more homogeneously, and thus more effectively, than cooling from the epicardium.
Also, the pigs treated with hypothermia showed higher CFR in the infarct-related coronary artery than the normothermia-treated pigs after reperfusion. Because CFR can be used as an indirect parameter for evaluating the function of coronary circulation (22–24), preservation of CFR in the hypothermia-treated pigs reflects better coronary microcirculation. Dae et al. (15) used sestamibi autoradiography to demonstrate that hypothermia preserves microvasculature functions, whereas Hale et al. (25) showed that hypothermia significantly improves coronary reflow and reduces the no-reflow area in a rabbit MI model. Our finding is thus in agreement with that of previous studies, namely, that hypothermia appears to improve coronary flow in MI.
One possible mechanism for the myocardial protection provided by hypothermia involves diminished metabolic demand on the ischemic myocardium. Previous animal studies have shown that hypothermia increases myocardial adenosine triphosphate preservation during both ischemia and reperfusion (26). From the fact that a significant reduction in infarct size was seen only in study 1, the reduction in metabolic demand within the ischemic myocardium may be one of the major mechanisms of the cardioprotection provided by hypothermia. Using an isolated rat liver model of ischemia and reperfusion, Zar et al. (27) showed that hypothermic-perfusion reduced the formation of reactive oxygen species as well as post-ischemic vascular resistance compared with findings for normothermic-perfusion. It is further known that oxidative stress plays an important role in the deterioration of cardiac function (28), and that excessive stress induces tissue necrosis. Moreover, a previous study has shown that antioxidant vitamin C restores coronary microcirculatory function (29). The findings of only our study, therefore, do not clearly rule out the possibility that the reduction in 8-iso-PGF2 may be a result rather than mechanisms. It was demonstrated, however, that isoprostans themselves possess biological activities such as vasoconstriction (30), and free radicals are thought to mediate reperfusion injury. These facts may support the hypothesis that the cardioprotective effect of hypothermia is, in part, due to reduced oxidative stress.
Study limitations.
In this study, the duration of coronary occlusion was 60 min, which is unrealistic for acute human MI. Because pigs tend to be much more frail than humans when it comes to ischemia, nearly all cells in the ischemic area in pigs hearts become necrosed after only 75 min of coronary occlusion (31). We, therefore, reduced the occlusion time to avoid death from heart failure and arrhythmia. In humans, however, the myocardial necrosis generally develops more slowly due to the greater collateral blood flow. Hypothermia may thus be beneficial for humans even when initiated later in the ischemic period. As for clinical application, a tool for monitoring the temperature, such as a thermo wire, would be helpful to keep the myocardial temperature within therapeutic levels.
On the basis of our preliminary findings, we believe that further experimental and clinical trials are warranted to determine whether adjunctive hypothermia therapy can limit infarct size during reperfusion therapy for MI.
Conclusions.
We successfully achieved catheter-based regional hypothermia within the ischemic myocardium. This method preserved CFR and attenuated oxidative stress, which may be beneficial for the recovery of cardiac function in acute MI. We speculate that transcoronary myocardial hypothermia may be an effective therapy, especially for patients with acute MI who are susceptible to ischemia-reperfusion injury.
|
References
|
|---|
1. Ferrari R, Alfieri O, Curello S, et al. Occurrence of oxidative stress during reperfusion of the human heart Circulation 1990;81:201-211.2. Kloner RA, Przyklenk K, Whittaker P. Deleterious effects of oxygen radicals in ischemia/reperfusionResolved and unresolved issues. Circulation 1989;80:1115-1127. 3. Li D, Williams V, Liu L, et al. Expression of lectin-like oxidized low-density lipoprotein receptors during ischemia-reperfusion and its role in determination of apoptosis and left ventricular dysfunction J Am Coll Cardiol 2003;41:1048-1055.[Abstract/Free Full Text] 4. Suzuki K, Murtuza B, Smolenski RT, et al. Overexpression of interleukin-1 receptor antagonist provides cardioprotection against ischemia-reperfusion injury associated with reduction in apoptosis Circulation 2001;104:308-313. 5. Herskowitz A, Choi S, Ansari AA, Wesselingh S. Cytokine mRNA expression in postischemic/reperfused myocardium Am J Pathol 1995;146:419-428.[Abstract] 6. Asanuma H, Minamino T, Sanada S, et al. ß-adrenocepter blocker carvedilol provides cardioprotection via an adenosine-dependent mechanism in ischemic canine hearts Circulation 2004;109:2773-2779. 7. Melo LG, Agrawal R, Zhang L, et al. Gene therapy strategy for long-term myocardial protection using adeno-associated virus-mediated delivery of heme oxygenase gene Circulation 2002;105:602-607. 8. Hayashi M, Tsutamoto T, Wada A, et al. Intravenous atrial natriuretic peptide prevents left ventricular remodeling in patients with first anterior acute myocardial infarction J Am Coll Cardiol 2001;37:1820-1826.[Abstract/Free Full Text] 9. Deng H, Han HS, Cheng D, Sun GH, Yenari MA. Mild hypothermia inhibits inflammation after experimental stroke and brain inflammation Stroke 2003;34:2495-2501.[Abstract/Free Full Text] 10. Kato A, Singh S, McLeish KR, Edwards MJ, Lentsch AB. Mechanism of hypothermic protection against ischemic liver injury in mice Am J Physiol 2002;282:G608-G616. 11. Zager RA, Altschuld R. Body temperature: an important determinant of severity of ischemic renal injury Am J Physiol Renal Physiol 1986;251:87-93. 12. Sakuma T, Takahashi K, Ohya N, et al. Ischemia-reperfusion lung injury in rabbits: mechanisms of injury and protection Am J Physiol Lung Cell Mol Physiol 1999;276:137-145. 13. Chien GL, Wolff RA, Davis RF, van Winkle DM. "Normothermic range" temperature affects myocardial infarct size Cardiovasc Res 1994;28:1014-1017.[Abstract/Free Full Text] 14. Hale SL, Dave RH, Kloner RA. Regional hypothermia reduces myocardial necrosis even when instituted after the onset of ischemia Basic Res Cardiol 1997;92:351-357.[Web of Science][Medline] 15. Dae MW, Gao DW, Sessler DI, Chair K, Stillson CA. Effect of endovascular cooling on myocardial temperature, infarct size, and cardiac output in human-sized pigs Am J Physiol 2002;282:H1584-H1591. 16. Dave RH, Hale SL, Kloner RA. Hypothermic, closed circuit pericardioperfusion: a potential cardioprotective technique in acute regional ischemia J Am Coll Cardiol 1998;31:1667-1671.[Abstract/Free Full Text] 17. Dixon SR, Whitbourn RJ, Dae MW, et al. Induction of mild systemic hypothermia with endovascular cooling during primary percutaneous coronary intervention for acute myocardial infarction J Am Coll Cardiol 2002;40:1928-1934.[Abstract/Free Full Text] 18. Walker MJ, Curtis MJ, Hearse DJ, et al. The Lambeth Conventions: guidelines for the study of arrhythmias in ischaemia infarction, and reperfusion Cardiovasc Res 1988;22:447-455.[Web of Science][Medline] 19. Krieger DW, De Georgia MA, Abou-Chebl A, et al. Cooling for acute ischemic brain damage (COOL-AID)An open pilot study of induced hypothermia in acute ischemic stroke. Stroke 2001;32:1847-1854.[Abstract/Free Full Text] 20. Marion DW, Penrod LE, Kelsey SF, et al. Treatment of traumatic brain injury with moderate hypothermia N Engl J Med 1997;336:540-546.[Abstract/Free Full Text] 21. The Hypothermia After Cardiac Arrest Study Group Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest N Engl J Med 2002;346:549-556.[Abstract/Free Full Text] 22. Gould KL, Lipscomb K, Hamilton GW. Physiologic basis for assessing critical coronary stenosis Am J Cardiol 1974;33:87-92.[CrossRef][Web of Science][Medline] 23. Uren NG, Melin JA, De Bruyne B, Wijns W, Baudhuin T, Camici PG. Relation between myocardial blood flow and the severity of coronary artery stenosis N Engl J Med 1994;330:1782-1788.[Abstract/Free Full Text] 24. de Silva R, Camici PG. Role of positron emission tomography in the investigation of human coronary circulatory function Cardiovasc Res 1994;28:1595-1612.[Web of Science][Medline] 25. Hale SL, Dae MW, Kloner RA. Hypothermia during reperfusion limits no-reflow injury in a rabbit model of acute myocardial infarction Cardiovasc Res 2003;59:715-722.[Abstract/Free Full Text] 26. Ning XH, Xu CS, Song YC, et al. Hypothermia preserves function and signaling for mitochondrial biogenesis during subsequent ischemia Am J Physiol 1998;274:H786-H793. 27. Zar HA, Tanigawa K, Lancaster Jr. JR. Mild hypothermia protects against postischemic hepatic endothelial injury and decrease the formation of reactive oxygen species Redox Rep 2000;5:303-310.[CrossRef][Web of Science][Medline] 28. Shite J, Qin F, Mao W, Kawai H, Stevens SY, Liang C. Antioxidant vitamins attenuate oxidative stress and cardiac dysfunction in tachycardia-induced cardiomyopathy J Am Coll Cardiol 2001;38:1734-1740.[Abstract/Free Full Text] 29. Kaufmann PA, Gnecchi-Ruscone T, di Terlizzi M, Schäfers KP, Lüscher TF, Camici PG. Coronary heart disease in smokers vitamin C restores coronary microcirculatory function Circulation 2000;102:1233-1238. 30. Takahashi K, Nammour TM, Fukunaga M, et al. Glomerular actions of a free radical-generated novel prostaglandin, 8-iso-prostaglandin F2, in the rat: evidence for interaction with thromboxane A2 receptors J Clin Invest 1992;90:136-141.[Web of Science][Medline] 31. Horneffer P, Healy B, Gott V, Gardner T. The rapid evolution of a myocardial infarction in an end-artery coronary preparation Circulation 1987;76(Suppl V):V39-V42.
Related Article
-
Cold Cardioplegia for Acute Infarction: A Viable Adjunct to Reperfusion Therapy?
- William Wijns and Guy R. Heyndrickx
J. Am. Coll. Cardiol. 2007 49: 261-262.
[Full Text]
[PDF]
This article has been cited by other articles:
|
|
|
|
 
D. J. Chambers
Myocardial Infarction Comes Into the Cold!
Ann. Thorac. Surg.,
January 1, 2009;
87(1):
8 - 10.
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. Hamamoto, H. Sakamoto, B. G. Leshnower, L. M. Parish, S. Kanemoto, R. Hinmon, T. Plappert, S. Miyamoto, M. G. St. John-Sutton, J. H. Gorman III, et al.
Very Mild Hypothermia During Ischemia and Reperfusion Improves Postinfarction Ventricular Remodeling
Ann. Thorac. Surg.,
January 1, 2009;
87(1):
172 - 177.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
W. Wijns and G. R. Heyndrickx
Cold Cardioplegia for Acute Infarction: A Viable Adjunct to Reperfusion Therapy?
J. Am. Coll. Cardiol.,
January 16, 2007;
49(2):
261 - 262.
[Full Text]
[PDF]
|
|
|
|
Top
Abstract
Methods
